Upadhyay Suketu

SEC source: 0001062993-24-006027 · form4.xml · derivative · entry 3

Upadhyay Suketu · CIK 0001533149 · Exec. VP, CFO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 9,119

Underlying: Common Stock · 4,561 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of Zimmer Biomet Holdings, Inc. common stock.

F3 · derivative.exercise_date: One-third of the RSUs vested on March 6, 2024. The remaining RSUs vest one-half on each of March 6, 2025 and March 6, 2026.

F3 · derivative.expiration_date: One-third of the RSUs vested on March 6, 2024. The remaining RSUs vest one-half on each of March 6, 2025 and March 6, 2026.

SEC source: 0001062993-24-006027 · form4.xml · nonDerivative · entry 2

Upadhyay Suketu · CIK 0001533149 · Exec. VP, CFO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 20,764

F1 · shares: Represents shares withheld by the Company to satisfy tax withholding obligations on the vesting of restricted stock units ("RSUs").

SEC source: 0001062993-24-006027 · form4.xml · nonDerivative · entry 1

Upadhyay Suketu · CIK 0001533149 · Exec. VP, CFO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 22,683

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001062993-24-004690 · form4.xml · derivative · entry 3

Upadhyay Suketu · CIK 0001533149 · Exec. VP, CFO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 7,043 shares

Expires 2024-02-25

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of Company common stock.

F1 · shares: This number of restricted stock units ("RSUs") reflects the adjustments that occurred as of March 1, 2022 in connection with Zimmer Biomet Holdings, Inc.'s (the "Company") spinoff of Zimvie Inc. In connection with the spinoff, each RSU was adjusted to preserve the intrinsic value of such award by multiplying it by an equity exchange ratio, rounded up to the nearest whole unit, which adjustments were made following the initial reporting of these RSUs.

SEC source: 0001062993-24-004690 · form4.xml · nonDerivative · entry 2

Upadhyay Suketu · CIK 0001533149 · Exec. VP, CFO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 18,122

F3 · shares: Represents shares withheld by the Company to satisfy tax withholding obligations on the vesting of RSUs.

SEC source: 0001062993-24-004690 · form4.xml · nonDerivative · entry 1

Upadhyay Suketu · CIK 0001533149 · Exec. VP, CFO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 20,213

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: This number of restricted stock units ("RSUs") reflects the adjustments that occurred as of March 1, 2022 in connection with Zimmer Biomet Holdings, Inc.'s (the "Company") spinoff of Zimvie Inc. In connection with the spinoff, each RSU was adjusted to preserve the intrinsic value of such award by multiplying it by an equity exchange ratio, rounded up to the nearest whole unit, which adjustments were made following the initial reporting of these RSUs.

F2 · balance_after: Includes 187 shares acquired under the Company's Employee Stock Purchase Plan through February 1, 2024.

SEC source: 0001062993-24-004133 · form4.xml · derivative · entry 1

Upadhyay Suketu · CIK 0001533149 · Exec. VP, CFO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 16,336

Underlying: Common Stock · 16,336 shares

Expires not disclosed

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Zimmer Biomet Holdings, Inc. common stock.

F2 · derivative.exercise_date: Vests annually over three years in increments of one-third each year, commencing February 20, 2025.

F2 · derivative.expiration_date: Vests annually over three years in increments of one-third each year, commencing February 20, 2025.

SEC source: 0001062993-23-014447 · form4.xml · derivative · entry 3

Upadhyay Suketu · CIK 0001533149 · Exec. VP, CFO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 3,768 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of Company common stock.

F3 · derivative.exercise_date: The remaining 3,768 RSUs in this grant vested on July 1, 2023.

F3 · derivative.expiration_date: The remaining 3,768 RSUs in this grant vested on July 1, 2023.

SEC source: 0001062993-23-014447 · form4.xml · nonDerivative · entry 2

Upadhyay Suketu · CIK 0001533149 · Exec. VP, CFO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 12,983

F1 · shares: Represents shares withheld by the Company to satisfy tax withholding obligations on the vesting of restricted stock units ("RSUs").

SEC source: 0001062993-23-014447 · form4.xml · nonDerivative · entry 1

Upadhyay Suketu · CIK 0001533149 · Exec. VP, CFO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 14,660

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001209191-23-027060 · doc4.xml · nonDerivative · entry 1

Upadhyay Suketu · CIK 0001533149 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,726

F1 · shares: Restricted stock unit award that vests, subject to certain limited exceptions, on the first anniversary of the grant date.

SEC source: 0001062993-23-006286 · form4.xml · derivative · entry 1

Upadhyay Suketu · CIK 0001533149 · Exec. VP, CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 13,680

Underlying: Common Stock · 13,680 shares

Expires not disclosed

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Zimmer Biomet Holdings, Inc. common stock.

F2 · derivative.exercise_date: Vests annually over three years in increments of one-third each year, commencing March 6, 2024.

F2 · derivative.expiration_date: Vests annually over three years in increments of one-third each year, commencing March 6, 2024.

SEC source: 0001062993-23-004620 · form4.xml · derivative · entry 3

Upadhyay Suketu · CIK 0001533149 · Exec. VP, CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 3,860 shares

Expires 2023-02-21

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of Company common stock.

F1 · shares: This number of restricted stock units ("RSUs") reflects the adjustments that occurred as of March 1, 2022 in connection with Zimmer Biomet Holdings, Inc.'s (the "Company") spinoff of Zimvie Inc. In connection with the spinoff, each RSU was adjusted to preserve the intrinsic value of such award by multiplying it by an equity exchange ratio, rounded up to the nearest whole unit, which adjustments were made following the initial reporting of these RSUs.

SEC source: 0001062993-23-004620 · form4.xml · nonDerivative · entry 2

Upadhyay Suketu · CIK 0001533149 · Exec. VP, CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,892

F3 · shares: Represents shares withheld by the Company to satisfy tax withholding obligations on the vesting of RSUs.

SEC source: 0001062993-23-004620 · form4.xml · nonDerivative · entry 1

Upadhyay Suketu · CIK 0001533149 · Exec. VP, CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 12,047

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: This number of restricted stock units ("RSUs") reflects the adjustments that occurred as of March 1, 2022 in connection with Zimmer Biomet Holdings, Inc.'s (the "Company") spinoff of Zimvie Inc. In connection with the spinoff, each RSU was adjusted to preserve the intrinsic value of such award by multiplying it by an equity exchange ratio, rounded up to the nearest whole unit, which adjustments were made following the initial reporting of these RSUs.

F2 · balance_after: Includes 206 shares acquired under the Company's Employee Stock Purchase Plan on June 30, 2022 and December 30, 2022.

SEC source: 0001209191-23-003744 · doc4.xml · derivative · entry 1

Upadhyay Suketu · CIK 0001533149 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 234.996

Underlying: Common Stock · 96.341 shares

Expires not disclosed

F1 · derivative.exercise_price: Each deferred stock unit represents one share of common stock and is paid out in common stock upon the earliest to occur of (i) termination of Mr. Upadhyay's service on our board of directors, (ii) a change of control of our company and (iii) Mr. Upadhyay's disability or death.

F1 · derivative.exercise_date: Each deferred stock unit represents one share of common stock and is paid out in common stock upon the earliest to occur of (i) termination of Mr. Upadhyay's service on our board of directors, (ii) a change of control of our company and (iii) Mr. Upadhyay's disability or death.

F1 · derivative.expiration_date: Each deferred stock unit represents one share of common stock and is paid out in common stock upon the earliest to occur of (i) termination of Mr. Upadhyay's service on our board of directors, (ii) a change of control of our company and (iii) Mr. Upadhyay's disability or death.

SEC source: 0000899243-22-033745 · doc4.xml · derivative · entry 1

Upadhyay Suketu · CIK 0001533149 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 138.655

Underlying: Common Stock · 96.861 shares

Expires not disclosed

F1 · derivative.exercise_price: Each deferred stock unit represents one share of common stock and is paid out in common stock upon the earliest to occur of (i) termination of Mr. Upadhyay's service on our board of directors, (ii) a change of control of our company and (iii) Mr. Upadhyay's disability or death.

F1 · derivative.exercise_date: Each deferred stock unit represents one share of common stock and is paid out in common stock upon the earliest to occur of (i) termination of Mr. Upadhyay's service on our board of directors, (ii) a change of control of our company and (iii) Mr. Upadhyay's disability or death.

F1 · derivative.expiration_date: Each deferred stock unit represents one share of common stock and is paid out in common stock upon the earliest to occur of (i) termination of Mr. Upadhyay's service on our board of directors, (ii) a change of control of our company and (iii) Mr. Upadhyay's disability or death.

SEC source: 0000899243-22-026340 · doc4.xml · derivative · entry 1

Upadhyay Suketu · CIK 0001533149 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 41.794

Underlying: Common Stock · 41.794 shares

Expires not disclosed

F1 · derivative.exercise_price: Each deferred stock unit represents one share of common stock and is paid out in common stock upon the earliest to occur of (i) termination of Mr. Upadhyay's service on our board of directors, (ii) a change of control of our company and (iii) Mr. Upadhyay's disability or death.

F1 · derivative.exercise_date: Each deferred stock unit represents one share of common stock and is paid out in common stock upon the earliest to occur of (i) termination of Mr. Upadhyay's service on our board of directors, (ii) a change of control of our company and (iii) Mr. Upadhyay's disability or death.

F1 · derivative.expiration_date: Each deferred stock unit represents one share of common stock and is paid out in common stock upon the earliest to occur of (i) termination of Mr. Upadhyay's service on our board of directors, (ii) a change of control of our company and (iii) Mr. Upadhyay's disability or death.

SEC source: 0001062993-22-015943 · form4.xml · derivative · entry 3

Upadhyay Suketu · CIK 0001533149 · Exec. VP, CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,768

Underlying: Common Stock · 3,768 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of Company common stock.

F4 · shares: Amount reflects the adjustments that occurred as of March 1, 2022 in connection with the Company's spinoff of ZimVie Inc. In connection with the spinoff, each outstanding RSU was adjusted to preserve the intrinsic value of such award by multiplying it by an equity exchange ratio, rounded up to the nearest whole unit.

F5 · derivative.exercise_date: 3,768 of the RSUs vested on July 1, 2022 and the remaining 3,768 RSUs are scheduled to vest on July 1, 2023.

F5 · derivative.expiration_date: 3,768 of the RSUs vested on July 1, 2022 and the remaining 3,768 RSUs are scheduled to vest on July 1, 2023.

F4 · derivative.underlying_shares: Amount reflects the adjustments that occurred as of March 1, 2022 in connection with the Company's spinoff of ZimVie Inc. In connection with the spinoff, each outstanding RSU was adjusted to preserve the intrinsic value of such award by multiplying it by an equity exchange ratio, rounded up to the nearest whole unit.

F4 · balance_after: Amount reflects the adjustments that occurred as of March 1, 2022 in connection with the Company's spinoff of ZimVie Inc. In connection with the spinoff, each outstanding RSU was adjusted to preserve the intrinsic value of such award by multiplying it by an equity exchange ratio, rounded up to the nearest whole unit.

SEC source: 0001062993-22-015943 · form4.xml · nonDerivative · entry 2

Upadhyay Suketu · CIK 0001533149 · Exec. VP, CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,982

F2 · shares: Represents shares withheld by the Company to satisfy tax withholding obligations on the vesting of restricted stock units ("RSUs").

SEC source: 0001062993-22-015943 · form4.xml · nonDerivative · entry 1

Upadhyay Suketu · CIK 0001533149 · Exec. VP, CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 9,231

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · balance_after: Includes 159 shares acquired under Zimmer Biomet Holdings, Inc. (the "Company") Employee Stock Purchase Plan between July 9, 2021 and January 10, 2022.

SEC source: 0000899243-22-018783 · doc4.xml · nonDerivative · entry 1

Upadhyay Suketu · CIK 0001533149 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,558

F1 · shares: Restricted stock unit grant vests on 5/18/2023.

SEC source: 0001062993-22-006634 · form4.xml · derivative · entry 2

Upadhyay Suketu · CIK 0001533149 · Exec. VP, CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,831

Underlying: Common Stock · 6,831 shares

Expires 2024-02-25

F1 · derivative.exercise_price: (1) Each restricted stock unit ("RSU") represents a contingent right to receive one share of Zimmer Biomet Holdings, Inc. common stock.

F2 · shares: In connection with the Company's spinoff of ZimVie Inc., certain performance-based restricted stock units ("PRSUs") held by Company employees, included the reporting person, were converted into time-based RSUs. Effective as of March 1, 2022, PRSU awards granted in 2020 were converted into RSUs at a 50% payout level and PRSU awards granted in 2021 were converted into RSUs at an 82.5% payout level. The vesting date of these awards remains the same, with the RSUs converted from 2020 PRSUs and 2021 PRSUs scheduled to vest on February 21, 2023 and February 25, 2024, respectively. Further, in connection with the spinoff, the RSUs will be adjusted pursuant to an exchange ratio, in order to preserve the intrinsic value of the original award. The RSUs reported on this Form 4 reflect the number of RSUs following conversion from PRSUs, but do not reflect the exchange ratio adjustment, as such calculations have not yet been completed.

F2 · derivative.underlying_shares: In connection with the Company's spinoff of ZimVie Inc., certain performance-based restricted stock units ("PRSUs") held by Company employees, included the reporting person, were converted into time-based RSUs. Effective as of March 1, 2022, PRSU awards granted in 2020 were converted into RSUs at a 50% payout level and PRSU awards granted in 2021 were converted into RSUs at an 82.5% payout level. The vesting date of these awards remains the same, with the RSUs converted from 2020 PRSUs and 2021 PRSUs scheduled to vest on February 21, 2023 and February 25, 2024, respectively. Further, in connection with the spinoff, the RSUs will be adjusted pursuant to an exchange ratio, in order to preserve the intrinsic value of the original award. The RSUs reported on this Form 4 reflect the number of RSUs following conversion from PRSUs, but do not reflect the exchange ratio adjustment, as such calculations have not yet been completed.

F2 · balance_after: In connection with the Company's spinoff of ZimVie Inc., certain performance-based restricted stock units ("PRSUs") held by Company employees, included the reporting person, were converted into time-based RSUs. Effective as of March 1, 2022, PRSU awards granted in 2020 were converted into RSUs at a 50% payout level and PRSU awards granted in 2021 were converted into RSUs at an 82.5% payout level. The vesting date of these awards remains the same, with the RSUs converted from 2020 PRSUs and 2021 PRSUs scheduled to vest on February 21, 2023 and February 25, 2024, respectively. Further, in connection with the spinoff, the RSUs will be adjusted pursuant to an exchange ratio, in order to preserve the intrinsic value of the original award. The RSUs reported on this Form 4 reflect the number of RSUs following conversion from PRSUs, but do not reflect the exchange ratio adjustment, as such calculations have not yet been completed.

SEC source: 0001062993-22-006634 · form4.xml · derivative · entry 1

Upadhyay Suketu · CIK 0001533149 · Exec. VP, CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,744

Underlying: Common Stock · 3,744 shares

Expires 2023-02-21

F1 · derivative.exercise_price: (1) Each restricted stock unit ("RSU") represents a contingent right to receive one share of Zimmer Biomet Holdings, Inc. common stock.

F2 · shares: In connection with the Company's spinoff of ZimVie Inc., certain performance-based restricted stock units ("PRSUs") held by Company employees, included the reporting person, were converted into time-based RSUs. Effective as of March 1, 2022, PRSU awards granted in 2020 were converted into RSUs at a 50% payout level and PRSU awards granted in 2021 were converted into RSUs at an 82.5% payout level. The vesting date of these awards remains the same, with the RSUs converted from 2020 PRSUs and 2021 PRSUs scheduled to vest on February 21, 2023 and February 25, 2024, respectively. Further, in connection with the spinoff, the RSUs will be adjusted pursuant to an exchange ratio, in order to preserve the intrinsic value of the original award. The RSUs reported on this Form 4 reflect the number of RSUs following conversion from PRSUs, but do not reflect the exchange ratio adjustment, as such calculations have not yet been completed.

F2 · derivative.underlying_shares: In connection with the Company's spinoff of ZimVie Inc., certain performance-based restricted stock units ("PRSUs") held by Company employees, included the reporting person, were converted into time-based RSUs. Effective as of March 1, 2022, PRSU awards granted in 2020 were converted into RSUs at a 50% payout level and PRSU awards granted in 2021 were converted into RSUs at an 82.5% payout level. The vesting date of these awards remains the same, with the RSUs converted from 2020 PRSUs and 2021 PRSUs scheduled to vest on February 21, 2023 and February 25, 2024, respectively. Further, in connection with the spinoff, the RSUs will be adjusted pursuant to an exchange ratio, in order to preserve the intrinsic value of the original award. The RSUs reported on this Form 4 reflect the number of RSUs following conversion from PRSUs, but do not reflect the exchange ratio adjustment, as such calculations have not yet been completed.

F2 · balance_after: In connection with the Company's spinoff of ZimVie Inc., certain performance-based restricted stock units ("PRSUs") held by Company employees, included the reporting person, were converted into time-based RSUs. Effective as of March 1, 2022, PRSU awards granted in 2020 were converted into RSUs at a 50% payout level and PRSU awards granted in 2021 were converted into RSUs at an 82.5% payout level. The vesting date of these awards remains the same, with the RSUs converted from 2020 PRSUs and 2021 PRSUs scheduled to vest on February 21, 2023 and February 25, 2024, respectively. Further, in connection with the spinoff, the RSUs will be adjusted pursuant to an exchange ratio, in order to preserve the intrinsic value of the original award. The RSUs reported on this Form 4 reflect the number of RSUs following conversion from PRSUs, but do not reflect the exchange ratio adjustment, as such calculations have not yet been completed.

SEC source: 0001062993-22-005351 · form4.xml · derivative · entry 1

Upadhyay Suketu · CIK 0001533149 · Exec. VP, CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 50,046

Underlying: Common Stock · 50,046 shares

Expires 2032-02-18

F1 · derivative.exercise_date: Vests annually over three years in increments of one-third each year, commencing on February 18, 2023.

SEC source: 0001062993-21-006235 · form4.xml · derivative · entry 3

Upadhyay Suketu · CIK 0001533149 · Exec. VP, CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,310

Underlying: Common Stock · 3,655 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of Company common stock.

F4 · derivative.exercise_date: The RSUs vest as follows: 3,655 vested on each of July 1, 2020 and July 1, 2021; and of the remaining 7,310 RSUs, 3,655 are scheduled to vest on each of July 1, 2022 and July 1, 2023.

F4 · derivative.expiration_date: The RSUs vest as follows: 3,655 vested on each of July 1, 2020 and July 1, 2021; and of the remaining 7,310 RSUs, 3,655 are scheduled to vest on each of July 1, 2022 and July 1, 2023.

SEC source: 0001062993-21-006235 · form4.xml · nonDerivative · entry 2

Upadhyay Suketu · CIK 0001533149 · Exec. VP, CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,304

F2 · shares: Represents shares withheld by the Company to satisfy tax withholding obligations on the vesting of restricted stock units ("RSUs").

SEC source: 0001062993-21-006235 · form4.xml · nonDerivative · entry 1

Upadhyay Suketu · CIK 0001533149 · Exec. VP, CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,416

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · balance_after: Includes shares acquired under Zimmer Biomet Holdings, Inc. (the "Company") Employee Stock Purchase Plan between July 9, 2020 and January 9, 2021.

SEC source: 0001062993-21-002095 · form4.xml · derivative · entry 1

Upadhyay Suketu · CIK 0001533149 · Exec. VP, CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 33,914

Underlying: Common Stock · 33,914 shares

Expires 2031-02-25

F1 · derivative.exercise_date: Vests annually over four years in increments of 25% each year, commencing on February 25, 2022.

SEC source: 0000911916-20-000165 · edgar.xml · derivative · entry 3

Upadhyay Suketu · CIK 0001533149 · Exec. VP, CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,965

Underlying: Common Stock · 3,655 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of Company common stock.

F3 · derivative.exercise_date: Vests annually over four years in increments of 25% each year, commencing on July 1, 2020.

F3 · derivative.expiration_date: Vests annually over four years in increments of 25% each year, commencing on July 1, 2020.

SEC source: 0000911916-20-000165 · edgar.xml · nonDerivative · entry 2

Upadhyay Suketu · CIK 0001533149 · Exec. VP, CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,576

F1 · shares: Represents shares withheld by Zimmer Biomet Holdings, Inc. (the "Company") to satisfy tax withholding obligations on the vesting of restricted stock units ("RSUs").

SEC source: 0000911916-20-000165 · edgar.xml · nonDerivative · entry 1

Upadhyay Suketu · CIK 0001533149 · Exec. VP, CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,655

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0000911916-20-000038 · edgar.xml · derivative · entry 1

Upadhyay Suketu · CIK 0001533149 · Exec. VP, CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 40,414

Underlying: Common Stock · 40,414 shares

Expires 2030-02-21

F1 · derivative.exercise_date: Vests annually over four years in increments of 25% each year, commencing on February 21, 2021.

SEC source: 0000911916-19-000151 · edgar.xml · derivative · entry 2

Upadhyay Suketu · CIK 0001533149 · Exec. VP, CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 14,620

Underlying: Common Stock · 14,620 shares

Expires not disclosed

F2 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Zimmer Biomet Holdings, Inc. common stock.

F1 · derivative.exercise_date: Vests annually over four years in increments of 25% each year, commencing on July 1, 2020.

F1 · derivative.expiration_date: Vests annually over four years in increments of 25% each year, commencing on July 1, 2020.

SEC source: 0000911916-19-000151 · edgar.xml · derivative · entry 1

Upadhyay Suketu · CIK 0001533149 · Exec. VP, CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 63,510

Underlying: Common Stock · 63,510 shares

Expires 2029-07-01

F1 · derivative.exercise_date: Vests annually over four years in increments of 25% each year, commencing on July 1, 2020.

SEC source: 0001209191-16-142897 · doc4.xml · nonDerivative · entry 1

Upadhyay Suketu · CIK 0001533149 · EVP, Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 22,412

F1 · date: Thirty-three percent (33%) of Mr. Upadhyay's September 24, 2013 grant of restricted stock units (RSUs) vested on September 24, 2016.

F2 · shares: These shares represent stock withheld by Endo International plc to satisfy Mr. Upadhyay's tax withholding obligations on shares acquired upon vesting of RSUs.

F3 · price: $22.44 represents the vesting price, which is the average of the high and low share price on September 23, 2016, the last business day prior to the vesting day, which was a Saturday.